CalciMedica director Eric Bjerkholt resigns; Alan Glicklich appointed to board

CalciMedica, Inc.

Eric Bjerkholt resigned as director and audit committee chair effective Jan 15, 2025; no disagreement with company.
Board appointed Alan Glicklich, M.D. as Class I director effective same date, term expires at 2027 annual meeting.
Dr. Glicklich receives $40,000 annual cash retainer (pro-rated) and option for 20,000 shares vesting over three years.
No arrangements or transactions requiring disclosure under Item 404(a) between Dr. Glicklich and company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alan Glicklich

Class I Director

CALC · CalciMedica, Inc.

Effective: 2025-01-15
Filed: January 14, 2025, 6:59 PM ET

On January 13, 2025, the Company’s Board appointed Alan Glicklich, M.D., as a Class I director of the Company, effective as of the Effective Date, with a term of office expiring at the 2027 annual meeting of stockholders.

Departed

Eric Bjerkholt

Director and Chair of Audit Committee

CALC · CalciMedica, Inc.

Effective: 2025-01-15
Successor: Alan Glicklich
Filed: January 14, 2025, 6:59 PM ET

On January 10, 2025, Eric Bjerkholt tendered his resignation as a member of the board of directors (the “Board”) of CalciMedica, Inc., a Delaware corporation (the “Company”) and as Chair and a member of the audit committee of the Board, effective as of January 15, 2025 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alan Glicklich was appointed as Class I Director at CalciMedica, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

On January 13, 2025, the Company’s Board appointed Alan Glicklich, M.D., as a Class I director of the Company, effective as of the Effective Date, with a term of office expiring at the 2027 annual meeting of stockholders.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Bjerkholt resigned as Director and Chair of Audit Committee at CalciMedica, Inc..

Action: resigned
Role: Director and Chair of Audit Committee

Exact text from the filing

On January 10, 2025, Eric Bjerkholt tendered his resignation as a member of the board of directors (the “Board”) of CalciMedica, Inc., a Delaware corporation (the “Company”) and as Chair and a member of the audit committee of the Board, effective as of January 15, 2025 (the “Effective Date”).

View on SEC.gov

CalciMedica, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-005654

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.